Published in Clin Chem on March 01, 2000
Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev (2013) 1.50
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis (2009) 1.43
Evaluation of Freeze Thaw Cycles on stored plasma in the Biobank of the Norwegian Mother and Child Cohort Study. Cell Preserv Technol (2008) 1.03
Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet. High Alt Med Biol (2011) 0.92
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib. J Lipid Res (2012) 0.88
Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial. Am J Clin Nutr (2016) 0.75
Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab (2016) 0.75
Programming of adiposity in childhood and adolescence: associations with birth weight and cord blood adipokines. J Clin Endocrinol Metab (2016) 0.75
Serum samples that have been stored long-term (>10 years) can be used as a suitable data source for developing cardiovascular risk prediction models in large observational rheumatoid arthritis cohorts. Biomed Res Int (2014) 0.75
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA (1993) 4.75
Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A (1999) 4.62
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med (1993) 4.61
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
The national glycohemoglobin standardization program: a five-year progress report. Clin Chem (2001) 4.24
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med (2001) 4.15
Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage (2002) 3.58
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Blood lipid measurements. Variations and practical utility. JAMA (1992) 2.40
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory. Diabetes Technol Ther (1999) 1.95
A midline dissociation between error-processing and response-conflict monitoring. Neuroimage (2003) 1.94
The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol (1988) 1.93
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation (2000) 1.85
Reevaluation of serum-plasma differences in total cholesterol concentration. JAMA (1990) 1.72
Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI. Magn Reson Med (2000) 1.69
Topical timolol decreases plasma high-density lipoprotein cholesterol level. Arch Ophthalmol (1990) 1.67
Amygdala response to both positively and negatively valenced stimuli. Neuroreport (2001) 1.60
Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study. Am J Med (1993) 1.56
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53
National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem (1995) 1.51
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med (1994) 1.46
Heterogeneity of HIV-1 and HIV-2. AIDS (1995) 1.41
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J (2000) 1.38
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Relationship between finger movement rate and functional magnetic resonance signal change in human primary motor cortex. J Cereb Blood Flow Metab (1996) 1.33
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Calmodulin-free skeletal-muscle troponin C prepared in the absence of urea. Biochem J (1981) 1.24
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2007) 1.22
Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise. Circulation (1982) 1.20
Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study. Brain Res (1998) 1.18
Mutational inversion of control of the lactose operon of Escherichia coli. J Mol Biol (1971) 1.18
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V. Arterioscler Thromb (1991) 1.17
Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol (1990) 1.17
The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol. Am J Med (1995) 1.16
Biomarkers for smoking cessation. Clin Pharmacol Ther (2013) 1.15
Functional MRI of human Pavlovian fear conditioning: patterns of activation as a function of learning. Neuroreport (1999) 1.15
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group. Am J Cardiol (1990) 1.13
A parametric manipulation of central executive functioning. Cereb Cortex (2000) 1.11
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol (1992) 1.11
Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther (1999) 1.09
Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem (1993) 1.09
Precipitation methods for quantification of lipoproteins. Methods Enzymol (1986) 1.08
Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am J Hum Genet (1986) 1.08
Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem (1990) 1.08
Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet (1981) 1.07
Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med (1998) 1.07
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res (1993) 1.06
Regional cerebral blood flow responses to variable frequency whisker stimulation: an autoradiographic analysis. Brain Res (2000) 1.05
Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J Pharmacol Exp Ther (1998) 1.04
Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem (2000) 1.04
High-affinity uptake and degradation of apolipoprotein E free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes. Biochemistry (1982) 1.03
Regulation of brain cyclic nucleotide phosphodiesterase by calmodulin. A quantitative analysis. J Biol Chem (1981) 1.02
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab (1990) 1.01
Functional MRI evidence for subcortical participation in conceptual reasoning skills. Neuroreport (1997) 1.01
High-density-lipoprotein cholesterol in heparin-MnCl2 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HCO3-. Clin Chem (1984) 1.01
Calcium, magnesium and the conformation of parvalbumin during muscular activity. Biochimie (1979) 1.00
Isolation and characterization of parvalbumins from the skeletal muscle of higher vertebrates. J Biol Chem (1974) 0.99
Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis (1987) 0.97
Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia. Atherosclerosis (1997) 0.97
Comparative properties of vertebrate parvalbumins. J Biol Chem (1977) 0.97
Determination of high density lipoprotein-cholesterol in stored human plasma. J Lipid Res (1980) 0.95
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy. J Am Coll Cardiol (2000) 0.95
High-density lipoprotein cholesterol measurements. A help or hindrance in practical clinical medicine? JAMA (1986) 0.95
Biochemical markers of compliance in the Physicians' Health Study. Am J Prev Med (1991) 0.95
Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: an in vivo electrochemical study. Neuroscience (1995) 0.95
Characterization of a new sarcoplasmic calcium-binding protein with magnesium-induced cooperativity in the binding of calcium. Biochemistry (1981) 0.94
Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Clin Chem (1986) 0.94
Isolation of a porcine liver plasma membrane fraction that binds low density lipoproteins. Biochemistry (1978) 0.93
Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. J Pharmacol Exp Ther (2000) 0.93
Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol (1999) 0.92
Free energy coupling in the interactions between Ca2+, calmodulin, and phosphorylase kinase. J Biol Chem (1983) 0.92
Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann Intern Med (1987) 0.92
Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia. Atherosclerosis (1987) 0.91
Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia. J Biol Chem (1991) 0.91
The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch Pathol Lab Med (1998) 0.90
Portacaval shunt in four patients with homozygous hypercholesterolaemia. Lancet (1975) 0.90
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. Am J Cardiol (1998) 0.90
Sleep disturbance and HMG CoA reductase inhibitors. JAMA (1990) 0.90
Ca2+-dependent regulation of calmodulin binding and adenylate cyclase activation in bovine cerebellar membranes. Biochim Biophys Acta (1982) 0.90
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism (2000) 0.90
Comparisons of referral criteria for public screening of blood cholesterol levels. Public Health Rep (1989) 0.90
Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol (1997) 0.89
The activation of rabbit skeletal muscle phosphorylase kinase requires the binding of 3 Ca2+ per delta subunit. Biochem Biophys Res Commun (1982) 0.89
The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. Pediatrics (1977) 0.89
Social play alters regional brain opioid receptor binding in juvenile rats. Brain Res (1995) 0.89
Co-ordination within and between verbal and visuospatial working memory: network modulation and anterior frontal recruitment. Neuroimage (2003) 0.89
Physical and chemical characterization of pig kidney particulate aminopeptidase. Helv Chim Acta (1971) 0.89
The purification and properties of detergent-solubilized rat liver nucleotide pyrophosphatase. J Biol Chem (1972) 0.89
Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. J Clin Endocrinol Metab (2001) 0.89
Matrix effects and the accuracy of cholesterol analysis. Arch Pathol Lab Med (1993) 0.89
Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast. Am J Psychiatry (2000) 0.89
Apolipoproteins AI, AII and B in young adults: associations with CHD risk factors. The Beaver County experience. J Chronic Dis (1986) 0.89
Standardization of lipid, lipoprotein, and apolipoprotein measurements. Clin Chem (1988) 0.88
Isolation and properties of a sarcoplasmic calcium-binding protein from crayfish. Biochemistry (1976) 0.88